Keros Therapeutics, Inc. · NASDAQ:KROS

D. E. Shaw & Co., L.P. reported a 5.10% stake in Keros Therapeutics, Inc. (Schedule 13G)

Event Oct 20, 2025 · Filed Oct 27, 2025

D. E. Shaw & Co., L.P. reported a 5.10% stake in Keros Therapeutics, Inc., 1,545,948 shares, as a passive investor on Oct 20, 2025. Filed Oct 27, 2025 (Schedule 13G).

Stake
5.10%
Shares
1,545,948
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
D. E. Shaw & Co., L.P.5.10%1,545,948
D. E. Shaw & Co., L.L.C.5.00%1,537,348
David E. Shaw5.10%1,545,948

Source

View original at SEC

Related